Are Medical Stocks Lagging Context Therapeutics Inc. (CNTX) This Year?

Zacks09-12

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Context Therapeutics Inc. (CNTX) been one of those stocks this year? Let's take ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2466204078?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","is_english":true,"pubTime":"2024-09-12 21:40","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2466204078","market":"us","top_or_hot":-1,"title":"Are Medical Stocks Lagging  Context Therapeutics Inc. (CNTX) This Year?","media":"Zacks","content":"<div>\n<p>Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Context Therapeutics Inc. (CNTX) been one of those stocks this year? Let's take ...</p>\n\n<a href=\"https://finance.yahoo.com/news/medical-stocks-lagging-context-therapeutics-134015581.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Are Medical Stocks Lagging  Context Therapeutics Inc. (CNTX) This Year?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAre Medical Stocks Lagging  Context Therapeutics Inc. (CNTX) This Year?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-12 21:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/medical-stocks-lagging-context-therapeutics-134015581.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Context Therapeutics Inc. (CNTX) been one of those stocks this year? Let's take ...</p>\n\n<a href=\"https://finance.yahoo.com/news/medical-stocks-lagging-context-therapeutics-134015581.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://finance.yahoo.com/news/medical-stocks-lagging-context-therapeutics-134015581.html","article_id":"2466204078","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xMhOxlfdhVA7Ts3pP3IHyA--~B/aD02MzM7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2466204078","pubTimestamp":1726148415,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Context Therapeutics Inc.  been one of those stocks this year?Let's take a closer look at the stock's year-to-date performance to find out.Context Therapeutics Inc. is a member of the Medical sector. This group includes 1019 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.The Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Context Therapeutics Inc. is currently sporting a Zacks Rank of #2 .For Collegium Pharmaceutical, the consensus EPS estimate for the current year has increased 2.3% over the p","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","COLL":"Collegium Pharmaceutical, Inc.","CNTX":"Context Therapeutics Inc."},"translate_title":"今年医疗股是否落后于Context Therapeutics Inc.(CNTX)？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CNTX":1,"COLL":1},"content_text":"Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Context Therapeutics Inc. (CNTX) been one of those stocks this year? Let's take a closer look at the stock's year-to-date performance to find out.\nContext Therapeutics Inc. is a member of the Medical sector. This group includes 1019 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.\nThe Zacks Rank emphasizes earnings estimates and estimate revisions to find stocks with improving earnings outlooks. This system has a long record of success, and these stocks tend to be on track to beat the market over the next one to three months. Context Therapeutics Inc. is currently sporting a Zacks Rank of #2 (Buy).\nOver the past three months, the Zacks Consensus Estimate for CNTX's full-year earnings has moved 15.3% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.\nOur latest available data shows that CNTX has returned about 89.4% since the start of the calendar year. Meanwhile, stocks in the Medical group have gained about 10.7% on average. As we can see, Context Therapeutics Inc. is performing better than its sector in the calendar year.\nOne other Medical stock that has outperformed the sector so far this year is Collegium Pharmaceutical (COLL). The stock is up 17.6% year-to-date.\nFor Collegium Pharmaceutical, the consensus EPS estimate for the current year has increased 2.3% over the past three months. The stock currently has a Zacks Rank #2 (Buy).\nBreaking things down more, Context Therapeutics Inc. is a member of the Medical - Drugs industry, which includes 180 individual companies and currently sits at #87 in the Zacks Industry Rank. Stocks in this group have lost about 0.1% so far this year, so CNTX is performing better this group in terms of year-to-date returns. Collegium Pharmaceutical is also part of the same industry.\nGoing forward, investors interested in Medical stocks should continue to pay close attention to Context Therapeutics Inc. and Collegium Pharmaceutical as they could maintain their solid performance.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nContext Therapeutics Inc. (CNTX) : Free Stock Analysis Report\nCollegium Pharmaceutical, Inc. (COLL) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2466204078"}